246 related articles for article (PubMed ID: 32125696)
1. Applying single-cell technologies to clinical pathology: progress in nephropathology.
Stewart BJ; Clatworthy MR
J Pathol; 2020 Apr; 250(5):693-704. PubMed ID: 32125696
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Pathology: the 2020 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Coates PJ
J Pathol; 2020 Apr; 250(5):475-479. PubMed ID: 32346919
[TBL] [Abstract][Full Text] [Related]
3. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
[TBL] [Abstract][Full Text] [Related]
4. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
[TBL] [Abstract][Full Text] [Related]
5. Features of increased malignancy in eosinophilic clear cell renal cell carcinoma.
Nilsson H; Lindgren D; Axelson H; Brueffer C; Saal LH; Lundgren J; Johansson ME
J Pathol; 2020 Dec; 252(4):384-397. PubMed ID: 32815150
[TBL] [Abstract][Full Text] [Related]
6. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.
Sjödahl G; Eriksson P; Liedberg F; Höglund M
J Pathol; 2017 May; 242(1):113-125. PubMed ID: 28195647
[TBL] [Abstract][Full Text] [Related]
7. Proteomic profiling identifies novel diagnostic biomarkers and molecular subtypes for mucinous tubular and spindle cell carcinoma of the kidney.
Xu H; Li W; Zhu C; Cheng N; Li X; Hao F; Zhu J; Huang L; Wang R; Wang L; Luo Z; Wang F
J Pathol; 2022 May; 257(1):53-67. PubMed ID: 35043389
[TBL] [Abstract][Full Text] [Related]
8. Integrated spatial and multimodal single-cell transcriptomics reveal patient-dependent cell heterogeneity in splenic marginal zone lymphoma.
Cerapio JP; Gravelle P; Quillet-Mary A; Valle C; Martins F; Franchini DM; Syrykh C; Brousset P; Traverse-Glehen A; Ysebaert L; Fournie JJ; Laurent C
J Pathol; 2024 Jun; ():. PubMed ID: 38828498
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors.
Dreijerink KM; Hackeng WM; Singhi AD; Heaphy CM; Brosens LA
J Pathol; 2022 Feb; 256(2):143-148. PubMed ID: 34750813
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
[TBL] [Abstract][Full Text] [Related]
11. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
14. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
[TBL] [Abstract][Full Text] [Related]
15. Clear cell carcinomas of the ovary and kidney: clarity through genomics.
Ji JX; Wang YK; Cochrane DR; Huntsman DG
J Pathol; 2018 Apr; 244(5):550-564. PubMed ID: 29344971
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
[TBL] [Abstract][Full Text] [Related]
17. IL-8 and CXCR1 expression is associated with cancer stem cell-like properties of clear cell renal cancer.
Corrò C; Healy ME; Engler S; Bodenmiller B; Li Z; Schraml P; Weber A; Frew IJ; Rechsteiner M; Moch H
J Pathol; 2019 Jul; 248(3):377-389. PubMed ID: 30883740
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma.
Singh NP; Vinod PK
Mol Genet Genomics; 2020 May; 295(3):807-824. PubMed ID: 32185457
[TBL] [Abstract][Full Text] [Related]
19. A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma.
Zhan X; Liu Y; Yu CY; Wang TF; Zhang J; Ni D; Huang K
BMC Med Genomics; 2020 Dec; 13(Suppl 11):190. PubMed ID: 33371886
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Pathology: the 2022 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Pillay N; Bankhead P; Coates PJ
J Pathol; 2022 Jul; 257(4):379-382. PubMed ID: 35635736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
